Making It In San Diego: Prescription Medication Costs Impacting San Diego Families

Prescription Medication CostsSAN DIEGO (KGTV) – Prescription Medication Costs


are pushing some San Diegans toward financial ruin.

Prescription drug prices are rising much faster than inflation rates in the United States, according to a recent article by ABC News . Experts describe the rising costs of prescription medication as unsustainable.

“I would say that it is catastrophically out of whack,” said Gloria Rickerd.

Around the start of 2018, Gloria Rickerd’s husband David was diagnosed with glioblastoma. It’s an aggressive type of brain cancer that can be very difficult to treat. Gloria says the average lifespan after diagnosis is between 12 and 24 months.

“Courtesy of having incredible doctors and good healthcare, he is still here after a year,” she said.

Along with the emotional toll etched into cancer treatment, there’s the financial toll. Procedures aren’t cheap, and the price of the medication can be lethal.

“A $400 copay for 15 capsules for a five-day supply,” Rickerd said.

David only has a handful of prescriptions, but without help, the co-payments could break their family financially. Gloria estimates 50 percent of their income goes to healthcare; 20 percent of that to medicines.

“It’s incredibly frustrating that families are expected to deal with these things without any training with limited resources,” she said.


According to a report from the AARP Public Policy Institute, the retail prices of some of the most popular prescription drugs take to treat everything from diabetes to high blood pressure to asthma increased by an average of 8.4 percent in 2017.

“People simply can’t afford their prescription drugs,” said Leigh Purvis, director of health services research for the AARP Public Policy Institute.

“The prices and costs associated with them have gotten so high that people are walking away from the pharmacy counter.”

Purvis says the main reason for the increase is because there’s nothing to stop it from happening.

“There’s nothing in the U.S. healthcare system that will stop drug manufacturers from setting really high prices and then increasing them pretty much whenever they want,” Purvis said.

She told 10News they are seeing a lot of brand name drugs coming on the market that aren’t facing generic competition.

Without competition, the costs can skyrocket.

According to the AARP’s “Rx Price Watch Report: Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans: 2017 Year-End Update” the annual average retail cost for just one popular brand-name drug among the 267 that AARP studied would have been nearly $6,800 in 2017. But had pharmaceutical price increases been limited to the country’s general inflation rate between 2006 and 2017, that cost would have been more than $4,600 lower. Retail prices increased in 2017 for 87 percent of the brand-name drugs studied.

“This really is an issue that affects everyone,” Purvis told 10News. “A lot of people tend to think about high prescription drug prices as something that only affects the people who are taking them, but that’s not the case. If you have healthcare coverage, your premiums and your cost sharing are being driven by high prescription drug prices even if you aren’t taking the product yourself. You also are paying taxes, and taxpayer-funded programs are paying a lot for prescription drug prices.”


While lawmakers debate ways to fix what many consider a crippling problem, there are simple solutions to cut some costs.

Some websites allow you to search prescriptions, compare costs by a pharmacy, and get coupons. If you have the option, experts 10News spoke with suggest buying in bulk through mail order. Also, if you’re at the pharmacy counter make sure to ask if there’s a generic or alternative available.Prescription Medication Costs

RELATED: Making It in San Diego: How to save money on your prescriptions

“I basically Googled patient assistance programs, patient copay assistant programs, and I listed the name of the drug I was looking for,” said Rickerd.

Gloria says she was able to call the manufacturer and find a program that eliminated the co-pays.

She says even if you think someone’s going to say no, it’s always worth trying to get a discount.


In San Diego, many people live close enough to the border they head to Mexico to buy prescription drugs at what they say is a lower price.

10News checked with U.S. Food and Drug Administration and Customs and Border protection on whether that’s even legal.

RELATED: Making It in San Diego: What you should know about traveling with prescription drugs, medications

A spokesperson for the FDA says in most circumstances, it is illegal for individuals to import drugs into the United States for personal use.

“The FDA cannot ensure the safety and effectiveness of medicine purchased over the internet from foreign sources, storefront businesses that offer to buy foreign medicine for Americans, or during trips outside the U.S. Such drugs present risks to American patients, including the risks that such drugs may be contaminated, counterfeit, contain varying amounts of active ingredients or none at all, and/or contain different ingredients than the FDA-approved product. In addition, the directions for use could be misleading or inaccurate, the recommended dosage may be harmful to the consumer, or the contraindications may not contain all of the products the user should avoid when taking the medication leading to serious injury, illness, or even death. For these reasons, FDA recommends only obtaining medicines from legal sources in the U.S.FDA’s personal importation policy [] (PIP) describes its enforcement priorities with respect to the importation of unapproved drugs for personal use. This policy is applied on a case-by-case basis and is specific to the individual merits and facts surrounding an individual’s drug offered for import. Under PIP, several factors are considered in determining whether or not the agency intends to object to certain personal imports of unapproved drugs:• The drug is for use for a serious condition for which effective treatment is not available in the United States;• There is no commercialization or promotion of the drug to U.S. residents;• The drug is considered not to represent an unreasonable risk;• The individual importing the drug verifies in writing that it is for his or her own use, and provides contact information for the doctor providing treatment or shows the product is for the continuation of treatment begun in a foreign country; and• Generally, not more than a 3-month supply of the drug is imported.”

Copyright 2019 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Lawsuits No Longer Lingering, Hippo Brings To Market Its Service For Buying Discount Drugs

DrugsThe long and litigious saga of Hippo Technologies may finally be over now that the company is finally launching its service to sell discounted prescription drugs to members just three months after settling a lawsuit with its chief competitor, Blink Health.

Hippo and Blink were locked in a lawsuit for much of last year, with Blink accusing the company of stealing pretty much every aspect of its business. For its part, Hippo’s chief executive and co-founder had sued Blink for wrongful termination under whistleblower protection rules after he allegedly uncovered corporate malfeasance at the discount drug membership service.

Both companies use a mobile app and online tool to help consumers find low prices on medications. In its March 2018 suit against Hippo, Blink wanted up to $250 million and had accused the company, which was founded by former Blink employees, of obtaining trade secrets, sabotaging existing contracts and unfairly competing with Blink’s business.

There’s no doubt that bad blood exists between Blink Health’s co-founders, the brothers Geoffrey and Matthew Chaiken, and Hippo co-founder Eugene Kakaulin.

A former chief financial officer at Blink, Kakaulin filed a suit in 2016 claiming that Blink had fired him in retaliation for alerting the company founders to security violations.

With most of those lawsuits now settled, Hippo is bringing its service to market. The company said that it can save patients up to 97 percent on their prescription drugs at almost any pharmacy in the country.

“People deserve to know how much they will pay for meds and get access to the lowest prices available. This is why we started Hippo,” said Kakaulin, the company’s co-founder, in a statement.

Kakaulin’s co-founder Charles A. Jacoby grew up in the healthcare business watching his father work as a general practitioner and grapple with prescribing patients with drugs that they can afford.

 “Markets are only fair and efficient when people are presented with pricing options. Whether people have good insurance, bad insurance or no insurance at all, they should check the Hippo price before going to the pharmacy,” Jacoby said in a statement.

Access to low-cost medicine is a significant part of what’s broken about healthcare in the U.S. today. Blink and Hippo are among a slew of companies trying to provide a fix, including GoodRX, Amazon (through its PillPack acquisition) and RxSave.

Hippo and its competitors operate on a simple premise. They cut out middlemen and guide consumers to use generic drugs, taking a cut of the sales from the drug manufacturers. The process saves customers money and can also generate some revenue for pharmacies that agree to work with the companies.Drugs

Pharmacy benefits managers aggregate the purchasing power of buyers through insurance networks to cut the prices that customers have to pay for their medications. But many people argue that the discounts are not significant, and most of the difference in cost just goes to line the pockets of the benefits managers themselves.

What companies like GoodRX, Hippo and Blink do is bring those benefits to anyone who signs up. Hippo gives participating pharmacies a guaranteed rate for drugs in exchange for lower prices. Sometimes the company will make money on the sale of a drug and sometimes it will lose money, but it ideally is profitable by arbitraging costs across a population.

To sign up for Hippo, potential customers can text “Hello” to Hippo (44776) on their phone or visit the company’s website to receive an individual, digital Hippo card.

Users can then compare costs between medications at local pharmacies and see which location is offering the best price. Once in the pharmacy a user just shows the pharmacist their Hippo card and can start saving.


Hy-Vee Expands Discount Medication List

As you were browsing something about your browser made us think you were a bot. There are a few reasons this might happen:


  • You’re a power user moving through this website with super-human speed.
  • You’ve disabled JavaScript in your web browser.
  • A third-party browser plugin, such as Ghostery or NoScript, is preventing JavaScript from running. Additional information is available in this support article.


To request an unblock, please fill out the form below and we will review it as soon as possible.

The Trusted Prescription Savings Card ScriptSave WellRx – discount leader

The Trusted Prescription Savings Card ScriptSave WellRx is brought to you by Medical Security Card Company, LLC, the trusted prescription discount leader at more than 62,000 pharmacies nationwide. See our online .Pharmacy certification. Compare Pharmacy Prescription Drug Prices ScriptSave® WellRx is the smart and trusted resource that makes prescription medicines more affordable and easier to manage, because ScriptSave WellRx cares about helping people stay healthy. ScriptSave WellRx is free to join, and we’re accepted nationwide at more than 62,000 pharmacies. Enter the prescription drugs you are searching for along with your address or zip code and compare pharmacy prices to find the best prescription drug prices in your area. You can also download our app and use its functionality on the go. How does the ScriptSave WellRx Card work?Simply present your ScriptSave WellRx card at any of the thousands of participating pharmacies nationwide to receive your instant savings. It’s that easy! Just show your card to the pharmacist each time you pick up your prescription, whether you’re filling for the first time or refilling. There is no paperwork to complete and no limit on usage.How much will I save with the ScriptSave WellRx Card?Savings average 54%, and, in some cases, can be 80% or more.* Savings vary based upon the medication and the pharmacy you choose to use. Start saving big on all of your medicine needs with ScriptSave WellRx.Do all pharmacies accept the ScriptSave WellRx Card?ScriptSave WellRx is accepted at 62,000 participating chain and independent retail pharmacies nationwide, so there’s likely a participating pharmacy nearby. Chances are the pharmacy you use now participates.For more answers to Frequently Asked Questions, visit our FAQs page.* Average and up to savings percentages are based on all discounted prescriptions that were run through the WellRx program in 2017. Discount percentages represent savings provided off of pharmacies’ retail prices for consumers who do not have a discount program and pay cash.

Discount Prescription Drug Card Scam | Medica Healthcare

FAQsHow do I use Blink for the first time?1. Search for your medication on or in our mobile app. 2. Prepay online to lock in your savings. We’ll text and email your proof of purchase — your Blink Card. 3. Bring your prescription to a participating pharmacy and have them fill it, as usual. 4. At pickup, show the pharmacist your Blink Card, and have them process it as the primary payor. You’ll pay nothing at the pharmacy.Do I need a prescription?Yes. You need a valid prescription from the doctor in order to use Blink. Blink does not prescribe medications.Does my pharmacy accept Blink?Local pharmacies serving every community accept Blink, including Walmart, Albertsons, Kroger, Kmart and many more. Most independent pharmacies also accept Blink. If your prescription is located at a pharmacy outside of the Blink Health network, transferring your prescription is simple. We’ll transfer your prescription after the checkout process – it’s free & easy.Does Blink contact my pharmacy to fill my prescription?No. Call your pharmacist to fill your prescription, like you always do. You can have your doctor call the prescription in, e-prescribe or provide you with a physical copy to give to the pharmacist. For existing prescriptions, request your refill from the pharmacy as you normally do and ask your pharmacist to process Blink as the primary payor.Can I use Blink if I have prescription drug coverage?Yes! Check the Blink Price and compare it to your coverage. If the Blink price is lower, purchase on Blink before going to the pharmacy. Ask the pharmacist to process Blink as the primary payor.Are there membership fees?There are absolutely no membership fees. Just pay for the medications you need, when you need them.

Drug Discount Card | NeedyMeds

How do I use Blink for the first time?1. Search for your medication on or in our mobile app. 2. Prepay online to lock in your savings. We’ll text and email your proof of purchase — your Blink Card. 3. Bring your prescription to a participating pharmacy and have them fill it, as usual. 4. At pickup, show the pharmacist your Blink Card, and have them process it as the primary payor. You’ll pay nothing at the pharmacy.Do I need a prescription?Yes. You need a valid prescription from the doctor in order to use Blink. Blink does not prescribe medications.Does my pharmacy accept Blink?Local pharmacies serving every community accept Blink, including Walmart, Albertsons, Kroger, Kmart and many more. Most independent pharmacies also accept Blink. If your prescription is located at a pharmacy outside of the Blink Health network, transferring your prescription is simple. We’ll transfer your prescription after the checkout process – it’s free & easy.Does Blink contact my pharmacy to fill my prescription?No. Call your pharmacist to fill your prescription, like you always do. You can have your doctor call the prescription in, e-prescribe or provide you with a physical copy to give to the pharmacist. For existing prescriptions, request your refill from the pharmacy as you normally do and ask your pharmacist to process Blink as the primary payor.Can I use Blink if I have prescription drug coverage?Yes! Check the Blink Price and compare it to your coverage. If the Blink price is lower, purchase on Blink before going to the pharmacy. Ask the pharmacist to process Blink as the primary payor.Are there membership fees?There are absolutely no membership fees. Just pay for the medications you need, when you need them.

What pharmacies accept SingleCare? Our pharmacy savings card is accepted nationwide at over 35,000 pharmacies, including CVS, Target, Longs Drugs, Walmart, Kroger, Fry’s, Harris Teeter, Walgreens, Duane Reade and many more. Simply bring your SingleCare card to the pharmacy and ask the pharmacist to process your prescription using the BIN and PCN number found on your card. To look up a drug price or to see if your pharmacy accepts SingleCare, search for your prescription at the top of this page. You can also search for your prescription on the SingleCare app, available for both Android and iOS. Why did I receive a prescription savings card? We work with a series of partners to help identify Americans who could benefit from SingleCare’s prescription savings. We believe all Americans should have access to the healthcare savings that SingleCare provides, so we invite individuals nationwide. Are over the counter medications covered? SingleCare’s prescription benefit only covers prescription medications. Some over-the-counter drugs, such as Advil, have stronger forms that require a prescription, and that form may be covered. I’m seeing a different price on the SingleCare site than at the store. Why? Our prices vary by pharmacy, and some pharmacies have multiple price points. At these pharmacies (Walmart and CVS) you may need to provide your name and email address on the SingleCare website to get the lowest price.

Pharmacy Steps Into Future With Pill Packer

It’s been easy to see how Keith Guy’s pharmacy network keeps growing, with a new store that just opened in Summit representing the most noticeable expansion.

Guy, who also owns the Medical Center Pharmacy on Marion Avenue in McComb, Southwest Discount Drugs in the Pike Center Mart and stores in Brookhaven in Crystal Springs, rarely sits still when it comes to his business. And lately he hasn’t had the opportunity to.

The long-anticipated opening of the Summit store last week coincided with another significant development for Guy — the installation of an automated pill packaging system at Southwest Discount Drugs, which will soon have a major logistical role in serving customers at all of Guy’s stores.

“This machine is the newest technology and it’s going to be the fastest,” said Guy, who had been looking at installing the device for the past 21⁄2 years and decided to hold off until an “easier, faster, newer” version of the RapidPakRX came out.

Pharmacists optically scan medication, which is photographed by a computer. They set up a dosage schedule and then load it into cartridges. The machine figures out how to package it all, spitting out perforated sleeves of cellophane packets of medication.

Labels on the packages have icons of the rising sun for pills to be taken in the morning, a sun for pills to be taken during the day and a moon for nighttime medications, with the recommended time of dosage printed on the label, as well as what’s inside each packet.

“It tells you the particular date you take them and what’s inside,” Guy said. “We can schedule it if they take one pill once a week.”

Store pharmacist Dennis Lee said the packages will help patients keep better track of their medication and make sure they’re not taking too much or too little of it. The convenience for customers can be seen in many other ways, he said.

“If you’re going to visit somebody for a weekend, you just tear off what you need, stick it in your purse or whatever,” Lee said.

With the addition of the RapidPakX, Southwest Discount Drugs will package medication for  customers who request the service at all of Guy’s locations.

“This is going to be central. We will fill for our other stores here,” Guy said, adding that customers can still choose to pick up their medication at whichever drug store they prefer. “I’ll actually have to fill the prescription here, but you won’t notice it.”

The pharmacy also will deliver the medications.

“We are going to deliver once a month to you, even if you lived in Byram,” Guy said, adding that deliveries will be done in about a 40-mile radius “all up and down I-55.”

The packaged medication comes in a white cardboard box.

“There are some exciting things going on that we hope to bring to this area. That’s been the goal down through the years,” Guy said.

Anti-Counterfeit Pharmaceutical Packaging Market Will Register A CAGR Of 12.6% By 2026

Wednesday, December 19, 2018

Press release from the issuing company

Future Market Insights (FMI) has published a new report, which is titled, “Anti-counterfeit Pharmaceutical Packaging Market: APEJ Regional Market to Register Healthy CAGR During the Forecast Period: Global Industry Analysis and Opportunity Assessment, 2016-2026.” The widespread counterfeiting of medicines has forced the pharma manufacturers to opt for secure solutions. One of the preventive measures these companies use is anti-counterfeiting packaging. It is estimated that globally around 10 to 15% medicines are counterfeited. Counterfeited medicines are fake medicines. Such medicines may be composed of the wrong ingredients or may be contaminated. This puts the global pharmaceuticals market in danger.

Fake medicines affect the pharma company’s reputation along with the patients. Thus, an increasing number of pharmaceutical companies are using anti-counterfeit solutions with the packaging of their products. Among the various packaging options, water, hologram and bar code are conventional methods. New and innovative options like integrating authentic overt features with covert elements, forensics and track and trace elements are being adopted by the pharmaceutical companies, thanks to the advancement in technology.

3M track and Trace solutions are expected to lead the entire market by 4.5% share and are expected to leave the other contenders behind. Avery Dennison and Sicpa Holdings are expected to give fierce competition to the market leaders during the projected period. This widespread and fragmented market is filled with competitors who offer anti counterfeit pharmaceutical packaging. In the current scenario these targeted companies are predicted to cover 12% of the entire market share and the rest will contribute to 82% of the global Anti-counterfeit pharmaceutical packaging market.

Region wise, North America is expected to dominate in the global anti-counterfeit pharmaceutical packaging market during the forecast period. Even in 2015, North America led the market for anti-counterfeit pharmaceutical packaging by accounting for 34% of the total share of the global market in terms of revenue. North America being the largest pharmaceuticals and biologics research hub, exports bio pharma products across all geographies. Another factor that will boost growth of the pharmaceutical sector in the region is the significant investment of companies in R&D.

The fastest growing market over the forecast period is predicted to be Latin America with a CAGR of 12.7% between 2016 and 2026. In MEA region Africa’s changing economic profile is influencing local as well as international players to expand their markets in the region. In the Middle East and Africa, the anti-counterfeit pharmaceutical market is estimated to expand at a fast paced CAGR of 11.5% by 2026 due to the growth in the economy of the region.

The anti-counterfeit pharmaceutical packaging is segmented on the basis of technology into security inks and coatings, security printing and graphics, RFID (active tags, semi active tags, passive tags) hologram, mass encoding (Barcode application, digital mass serializatio) and others (Electromagnetic, Surveillance technologies). The value of RFID technology segment in the global anti-counterfeit pharmaceutical packaging market was US$331.8 mn in 2015 and is expected to come close to a market value of US$1,146.8 mn by 2026, expanding at a CAGR of 12.3% from 2016 to 2026. The segment is anticipated to create an incremental $ opportunity of US$ 786.8 Mn between 2016 and 2026.

The global anti-counterfeit pharmaceutical packaging market is segmented on the basis of usage feature as convert features, forensic markers, divert features, tamper evidence, and track & trace technologies. The track & trace technologies segment is predicted to be worth US$ 2,742.5 mn by 2026 and expand at a CAGR of 13.1% over the forecast period. The track and trace segment is estimated to account for 40% by 2026.

Do Inquiry to Get the Sample of Report Here @

To post a comment Log In or Become a Member, doing so is simple and free


Innovate And Win The Future Through Intelligence, P-MEC China 2019 To “Set Sail” Intelligently

SHANGHAI, Dec. 17, 2018 /PRNewswire/ — The National Medical Products Administration of China officially issued the Guiding Opinions on Building Information Technology-Enabled Drug Traceability Systems in Nov. 2018. The introduction of this Guiding Opinions marks the return of the drug traceability system after the electronic supervision code system was halted in 2016. Tracking and source tracing of information in pharmaceutical production, circulation, and use, etc. through information-technology-enabled means to form an organic whole will become a development trend of the industry in the future. Chinese pharmaceutical enterprises have attached greater importance to the improvement of enterprise information management as successive favorable policies are introduced.

P-MEC China 2019, a grand international party for the industry exchange and cooperation, and common development in the pharmaceutical field that is hosted by China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) and UBM EMEA and co-sponsored by Shanghai UBM Sinoexpo International Exhibition Co., Ltd. (UBM Sinoexpo), will “set sail” intelligently on June 18-20, 2019 at Shanghai New International Expo Centre. The exhibition will further upgrade and optimize the Pharma Automation & Information Zone first launched in 2018 – it will be located in Hall N1 to co-locate with global leading pharmaceutical equipment manufacturers. The “Automation and Informatization Forum” will also be held concurrently, to provide pharmaceutical enterprises and pharmaceutical equipment enterprises with an efficient platform for display, exchange, cooperation, and learning.

To help the Chinese pharmaceutical producers welcome the new era of intelligent production

Tang Jiliang, a former researcher of Shanghai Institute of Pharmaceutical Industry, said in an interview, “The real intelligent manufacturing can effectively shorten product development, increase production efficiency, improve product quality, and reduce resource and energy consumption. All those advantages are what traditional pharmaceutical industry lacks and urgently needs. In the coming years, intelligent manufacturing will become a development trend of the global pharmaceutical industry that serves as a part of the manufacturing industry.”

P-MEC China is a prestigious event of the pharmaceutical engineering and machinery industry in China and Asia-Pacific region. The host, in order to accurately show the current situation of pharmaceutical automation and informatization in China and assist pharmaceutical enterprises to achieve compliant and efficient development, will make every effort to increase promotion of the Pharma Automation & Information Zone in 2019, so as to attract industry top enterprises to join. The zone will cover three aspects: system integration (providing overall project solutions and implementation schemes), automatic products (robots, manipulators, mechanical transmission products, AGV automatic logistics equipment and systems, mechanical lifting and handling equipment, packaging and sorting products, sensors, controllers, inverters, and instruments and valves, etc.), and information system (MES, ERP system, cGMP management system, CaaS, IDC-internet data center, and industrial big data service), to give visitors a close look at the leading techniques in the global intelligent manufacturing field.

To focus on the pharmaceutical intelligent manufacturing and achieve upgrading and transformation of traditional industry

Besides the product display, there will be a 1.5-day “Automation and Informatization Forum” held in the Pharma Automation & Information Zone, to directly touch upon core elements of pharmaceutical intelligent manufacturing. The host will invite international top technology providers and representatives of Chinese leading pharmaceutical enterprises, to share and discuss the most popular information applications presently in use as well as automatic production process upgrading, bringing visitors a deluge of intelligent knowledge. The forum will cover fascinating topics including “Multi-place Coordinated Production of Pharmaceutical Enterprises based on Digitalization and Informatization”, “From R&D to Production–How to Largely Increase Efficiency through Transparent and Complete Information Data”, “A Focus on Pharma 4.0–What Do We Lack for Achieving Intelligent Pharma?”, and “How to Achieve Robustness Improvement of the Production Process through Perfection of Data Integrity”.

Story continues

How to Become a Pharmacist|Pharmacy School & Pharmacist Careers

The most vulgar pharmacist place are that of a likeness pharmaceutist (also referred to as a mention pharmacist, first-impregnate druggist or dispensation chemist), or a inn druggist, where they instruct and counsel on the proper use and adverse effects of medically direct drugs and medicines.[3][4] In most countries, the profession is substance to trade regulation. Depending on the constitutional scope of artifice, pharmacists may contribute to prescribing (also referred to as “druggist prescriber”) and administering undeniable medications (e.g., immunizations) in some jurisdictions. Pharmacists may also practice in a sort of other settings, comprehend industry, wholesaling, study, academia, militia, and direction.

Bureau of Labor Statistics

School students must take a general exam to inscribe a school of pharmacy or the pharmacy department of a school of medicine and pharmacy. About 5–7% of students can come the exam. There are 3 aspects to the exam. These are on math, chemistry, and physics or biology. After being drag in the institute students retain a 5-year celibate’s degree in pharmacy. Or they are uni pharmacists (university pharmacist to differentiate between college pharmaceutist or vocational pharmacist in some countries of the earth these druggist are call pharmaceutist assistants). An option method of succeed a celibate’s position is as accompany. School pupils study in a college of pharmacy or a vocational teach of pharmacy. After attending the school or college they go to performance. And with two yonks of plot they could take an exam to enter institute of pharmacy or the pharmacy departure of a university of medication and pharmacy. This exam is easier than the public one. Passing the exam they persist meditation to easy 3-year bachelor’s degrees or 4-year celibate’s degrees. This position is estimate equivalent to a 5-year celibate’s degree.

Description of a Clinical Pharmacist Position |

What is a Pharmacist? What is a Pharmacist? The white-coated professionals at your proximity dose abundance do a lot more than just fill prescriptions. Pharmacists do indeed administer medicines, but first they tally for any possible interactions with other prescription or iatric mode. They also furnished patients on how to take the medicines and will deformed them approximately what to do if unhesitating side manifestation proceed. A druggist will also keep meticulous attestation, coordinate with underwrite assembly, superintend pharmacy technicians and keep up-to-misdate with connect education succession.”Pharmacists are comely a more perfect part of the eucrasy concern team,” sample Heather Free, a druggist operation in the District of Columbia. She says that pharmacists are up more to nourish adulterate and clinicians, for instance, by benefaction patients immunizations and doing sure that all of a patient’s doctors are deformed about the diverse cure that have been appoint. Some pharmacists are also getting involved in adhesion supervise (why it’s hard for a patient to take his/her eat) and medication therapeutics care, or MTM, which search to optimise what drugs do for a subject’s overall well-being.The unique mingle of medicinal cognizance and interpersonal skills required to proceed a pharmacy counter stay in imposition. Over the next decennary, more Americans are think to beseech haleness office forwhy they’re getting older and kindred are flowing longer. However, the Bureau of Labor Statistics devise a 6 percent trade growth for pharmacists by 2026, with the field mention 17,600 renovated jobs. Employment of pharmacists is think to shun marginally in traditive mention settings because more community are having their prescriptions filled online or through spot fashion. Quick Stats $122,230 Median Salary 2.0% Unemployment Rate 17,600 Number of Jobs

The novel business party for pharmacist as prescriber has been acknowledge in the UK since May 2006, exhort the “Pharmacist Independent Prescriber”. Once fit, a druggist self-reliant prescriber can appoint any licensed medicine for any iatrical requisite within their competence. This includes controlled drudge except schedule 1 and prescribing undeniable drugs for the treat of inclination (cocaine, heroin and dipipanone).[20]

Buy Cheap Prescription Drugs Online |

Amazon Buys Online Pharmacy In Move Into Drug Business

Amazon announced Thursday that it is acquiring the online pharmacy PillPack, a sign of its long-rumored push into the pharmacy business.

Shares of CVS and Walgreens declined on the news of Amazon’s purchase.

“PillPack’s visionary team has a combination of deep pharmacy experience and a focus on technology,” said Jeff Wilke, the head of Amazon’s consumer branch. “PillPack is meaningfully improving its customers’ lives, and we want to help them continue making it easy for people to save time, simplify their lives, and feel healthier. We’re excited to see what we can do together on behalf of customers over time.”


PillPack delivers drugs in pre-sorted packaging to match the dosage.

The acquisition by Amazon comes as a range of companies are exploring mergers that could disrupt the health care system.

Amazon is also working with JP Morgan Chase and Berkshire Hathaway on a new health-care company that is seeking to lower costs and improve care. The specifics of what the company will do, though, are still unknown.

The new health-care company did recently announce a CEO, Atul Gawande, a surgeon well known for his writing in the New Yorker about the health system.

Future Pharmacist- Definition of Clinical Pharmacy


The United States government is a massive employer, and is always looking for qualified candidates to fill a wide variety of open employment positions in locations across the country. Below you’ll find a Qualification Summary for an active, open job listing from the Department of Veterans Affairs. The opening is for a Clinical Pharmacy Specialist in Green Bay, Wisconsin Feel free to browse this and any other job listings and reach out to us with any questions!

Clinical Pharmacy Specialist – Green Bay, WisconsinVeterans Affairs, Veterans Health Administration, Department of Veterans AffairsJob ID: 15097Start Date: 11/09/2018End Date: 11/14/2018

Qualification SummaryTo qualify for this position, applicants must meet all requirements within 30 days of this announcement. Basic Requirements:Citizenship: Must be a Citizen of the United States. (Noncitizens may be appointed when it is not possible to recruit qualified citizens in accordance with VA Policy.)English Language Proficiency: You must be proficient in spoken and written English as required by 38 U.S.C. 7402(d), and 7407(d).Education: Must be a graduate of an Accreditation Council for Pharmacy Education (ACPE) accredited College or School of Pharmacy with a baccalaureate degree in pharmacy (BS Pharmacy) and/or a Doctor of Pharmacy (Pharm.D.) degree. (TRANSCRIPTS REQUIRED)ORMust be a graduate of a foreign pharmacy degree program that meets the educational requirement if the graduate is able to provide proof of achieving the Foreign Pharmacy Graduate Examination Commission (FPGEC) Certification, which includes passing the Foreign Pharmacy Graduate Equivalency Examination (FPGEE) and the Test of English as a Foreign Language Internet-Based Test (TOEFL iBT). (DOCUMENTATION REQUIRED)Licensure: Must possess a full, current, and unrestricted license to practice pharmacy in a State, Territory or Commonwealth (i.e., Puerto Rico) of the United States, or in the District of Columbia. (MUST PROVIDE A COPY) Grade Determinations: In addition to the Basic Requirements above, applicants must meet the following grade requirements. SPECIALIZED EXPERIENCE GS-13 LEVEL: You must have at least one (1) year of experience equivalent to the next lower grade level (GS-12) or equivalent, which is directly related to the Clinical Pharmacy Specialist position. The clinical pharmacy specialist (CPS) functions include, but are not limited to: designing, implementing, assessing, monitoring and documenting therapeutic plans utilizing the most effective, least toxic and most economical medication treatments; helping achieve positive patient centric outcomes through direct and indirect interactions with patients, providers, and interdisciplinary teams in assigned areas; performing physical assessments; and ordering laboratory and other tests to help determine efficacy and toxicity of medication therapy.ORYou must have completed 1 year Post Pharm D. ASHP accredited Residency.In addition, you must fully demonstrate the following KSAs:1. Ability to communicate orally and in writing to persuade and influence clinical and management decisions.2. Expert understanding of regulatory and quality standards for their program area.3. Ability to solve problems, coordinate and organize responsibilities to maximize outcomes in their program area or area of clinical expertise.4. Expert knowledge of a specialized area of clinical pharmacy practice or specialty area of pharmacy.5. Advanced skill in monitoring and assessing the outcome of drug therapies, including physical assessment and interpretation of laboratory and other diagnostic parameters. References: VA HANDBOOK 5005/55, PART II, APPENDIX G15. This can be found in the local Human Resources Office. The full performance level of this vacancy is GS-13. Physical Requirements: This position has been evaluated as a Level 1 in accordance with the Occupational Safety and Health Administration (OSHA) definition of occupational exposure to blood borne pathogens. Positions in this category require the performance of tasks that are exposed to blood and potentially infectious body fluids. See VA Directive and Handbook 5019.

If you’d like to submit a resume or apply for this position, please contact Premier Veterans at All are free to apply!


Post a job on LemonWire. Email to advertise on listings like this? Email

Pharmacists Challenge Council On More Spaces For Interns, Other Issues

Association of Hospital and Administrative Pharmacists of Nigeria (AHAPN) has challenged the Pharmacists Council of Nigeria (PCN) on the provision of more spaces for fresh pharmacy graduates due for internship.

The association said it is no longer news that pharmacy graduates roam the streets in search of nonexistent spaces for their mandatory one year internship, which has assumed a worrisome dimension. The body made this known when it paid a courtesy visit on PCN Registrar, Elijah A.  Mohammed, in Abuja.

While presenting him an award for the innovations introduced in steering the ship of the council forward, which included the introduction of online registration and renewal of annual licenses by pharmacists, which has removed the bottlenecks surrounding manual registration, he was also commended for the introduction of Online Mandatory Continuing Professional Development (MCPD).

According to AHAPN National Chairman, Dr. Kingsley Chiedu Amibor, innovations introduced by the registrar have improved the efficiency of the learning process, and saved valuable time and resources for pharmacists, who had to travel long distances to participate in the programme in different states and zones of the country with the attendant risks.

The Registrar was equally commended for strengthening pharmaceutical inspectorate activities nationwide, which have resulted in the closure of many illegal and unregistered premises, which before now, had served as reservoir for unwholesome and adulterated medicines.

They association also commended the robust relationship that exists between the PCN and the Pharmaceutical Society of Nigeria (PSN). The association equally commended efforts being made at reviewing the obsolete pharmacy laws.

While commending the PCN for authoring the document for central placement of interns, it observed that the process has not commenced yet, resulting in untold hardship for graduates and parents, who are compelled to keep catering for their children and wards years after leaving school.

Dr. Amibor said: “We believe the PCN is in a position to enforce legislation that will compel industries and employers of labour in the country to absorb more interns in their various establishments for their training programme. The Council should also bring pressure to bear on the management of tertiary and other health institutions to increase the number of internship slots for pharmacy and other interns from other disciplines.

“The Council is also encouraged to increase the number of community pharmacies accredited to train pharmacy interns in their various community outlets. And of course, universities, research institutes and pharmaceutical industries should be allocated a minimum number of slots for internship placement.”

The association urged the Council to be decisive on matters of accreditation of health care institutions intending to establish pharmacy departments in their hospitals.

“What we are simply saying is that the PCN should put its feet down and insist on following specifications when it comes to inspection or accreditation of health care institutions, since pharmacy practice would be better off for it. Similarly, we are aware that most private hospitals in Nigeria do not have pharmacists in their employment. I had the privilege of visiting one of such big private hospital, and asked for the pharmacist on duty, only to be told that the pharmacist does not work during the weekends. So, who covers the pharmacy at such times?” Dr. Amibor asked.

The association also lamented the acute shortage of pharmacists in government hospitals and healthcare institutions in Nigeria.  ”It is a common knowledge that there is paucity of pharmacists covering the various health institutions in Nigeria, including those at federal, state and private levels. This trend can no longer be allowed to continue. It also falls short of the World Health Organisation (WHO) recommended standard of 1 pharmacist per 2000 population. The matter is worse with government hospitals. We urge the PCN to champion advocacy for employment of more pharmacists in government hospitals in Nigeria, in collaboration with PSN and AHAPN.”

The Association touched on the mismanagement of Drug Revolving Fund scheme in various hospitals nationwide.

Amibor said: “We wish to bring to your notice the impunity going on with the management of drug revolving funds by government hospitals across the country. Some chief medical directors are resorting to buying pharmaceutical consumables from the open drug market; some others are encouraging store attendants to bye-pass pharmacists and issue medicines directly to end users. This practice is definitely not acceptable to us and must be discouraged.

“Several resolutions were taken at the recently concluded 20th Annual National Scientific Conference of AHAPN in Port Harcourt, which had as its theme: ‘Functional Drug Revolving Funds for Sustainable Medicines Availability and National Security.”

Another area of concern to the association was the exclusion of pharmacy students from clinical rotation in government hospitals. “Patient care globally is a collaborative practice; hence no group or individual should lay claim to ownership of patients, especially in government hospitals. We urge the PCN to immediately enter into discussion with relevant authorities to remove all hindrances and bottlenecks against pharmacy students from acquiring hands-on experience in their various places of learning,” Dr. Amibor said.

The association further sought the Council’s assistance in its resolve to adopt and implement pharmaceutical care as a philosophy of practice in Nigeria.

Other areas included government sponsorship of pharmacists for the doctor of pharmacy conversion programme; appropriate placement of holders of doctor of pharmacy (PharmD) degree in the scheme of service for pharmacists, in line with international best practice; release of Consultancy Circular for fellows of the West African Post Graduate College of Pharmacists (WAPCP), which is long overdue, and removal of all forms of career stagnation involving members in government hospitals.

The association pleaded with the Registrar to encourage his pharmacy staff, who are automatic members of the association, to identify with all the activities embarked upon by the association.

The association also decried the practice of non pharmacists taking over the jobs of qualified ones.  “We are aware that all kinds of people are taking over jobs hitherto reserved for pharmacists as medical representatives in industries. Although this does not affect us directly as hospital and administrative pharmacists, nevertheless, we are pharmacists and we are not at all impressed that charlatans and mediocres are taking over jobs meant for our colleagues. We urge the Council to look into this trend with a view to putting a stop to it.”

The team included Peter Iliya, Deputy Director, Public Relations; Baba Shehu Ahmed, Director Planning, Research and Statistics; Anthony Idoko, Deputy Director Education and Training; Mr. K.I. Munir, Deputy Director, Administration and Mr. O. A. Wefayo, Director Finance and Accounts.

On lack of internship space for fresh pharmacy graduates, the registrar said the PCN was the first to write for central placement of interns, but the process was hijacked. He said the council was deeply worried about the plight of fresh graduates and was weighing the various options before the Council. One of such options is to treat the interns in the same way as corps members (National Youth Service Corp members), they are pulled out of the general salary structure, and placed on monthly allowances.

Other options according to him included opening of more spaces in industries and community pharmacies and encourage universities to return their best graduates for the internship programme. He mentioned that there are over 300 outlets accredited for internship, but they are obviously grossly inadequate. He promised that the number of spaces would definitely increase next year.

On inspection of hospitals, he said inspectorate teams are now being headed by professors, promising that AHAPN members will subsequently be included in the teams. He also touched on the need for harmony in the healthcare sector, promising that he would be meeting with the leadership of the Nigerian Medical Association (NMA) in this regard.

He mentioned that all the 46 legal cases pending before the Council at the instance of NAPPMED had been dispensed with, and the Council was now free from legal encumbrances. He added that patent medicine vendors are already being regulated by the council.

Mohammed promised that the Council will support the adoption of pharmaceutical care as a philosophy of Pharmacy practice, pledging that non-governmental organisations (NGOs) will be recruited to assist.

For pharmacists employed in the pharmaceutical firms, the Registrar said there is a new law awaiting presidential consent that will mandate all such firms to register with the PCN. According to him, it will make for ethical products to be handled strictly by pharmacists. The new law will also address codeine abuse.

The Registrar promised that  Drug Revolving Fund (DRF) will be addressed more seriously next year. He regretted how pharmacy students are being denied access to patients bedside by hospital management, despite international best practice, promising that the Council will look into it with a view to working out an amicable solution together with other stakeholders.

Mohammed commended the association for the Award bestowed on him and promised that the award will spur him to sacrifice more for the profession.